Rohit Chauhan submits:
About
Johnson and Johnson (JNJ) is a US based pharma and healthcare company. The company has three primary business segments – consumer products, pharmaceuticals and medical devices.
Complete Story »
Go to Source

• 0 Comments

Jeffrey Dean Brown submits:
I always try to remain objective about the stocks that I write about and invest in. I have experienced the pain of falling in love with a stock that blinds me to its warts and blemishes. I must admit that I am very attracted to the stock that is the [...]

• 0 Comments

Recently, Genzyme (GENZ) has been in the news more than Lindsay Lohan because of the viral contamination problems at its Boston suburb facility. The analysts covering Genzyme have been mixed about its prospects - UBS and Goldman both downgraded Genzyme citing the manufacturing issues and a competing drug being developed by Shire plc (SHPGY). On [...]

• 0 Comments

,a href=’http://www.dominoanalytics.com/’>Brian Coleman submits:
China Medicine (CHME) is scheduled to report 2Q’09 earnings this Thursday morning, August 13. While there is no consensus estimates or management guidance for investors to base expectations on, we believe the company’s balance sheet offers some important clues as it pertains to ball-parking China Medicine’s results. And these clues lead us [...]

• 0 Comments

Carl T. Delfeld submits:
Long-time members know that Indonesia (IF) has been a favorite of mine that is oftentimes overlooked by even savvy global investors.
This year, it is one of the best performers in the world with a growth rate just a bit behind China. Other attributes are its rich natural resources, less reliance on [...]

• 0 Comments